Gari Gono is Head of Solutions for INSTANDA. Leading the global strategic platform roadmap he enables insurers, brokers and MGAs successfully design, build and deploy world-class digital insurance solutions that create value.
Gari believes that no code digital insurance platforms are fundamental to transforming the insurance industry. He has deep domain insurance expertise following leading Solutions Architect and Technology Consultant roles at Zurich and Deloitte Digital.
In addition to leading Solutions at INSTANDA, Gari is the podcast creator and host of ‘More Brown in Town, a podcast that addresses diversity and tackles conversations about racial diversity within the workplace.
BSc in Pharmacy, MSc in Pharmaceutical Industry and Technology, MSc in Pharmaceutical Biotechnology. Currently studying an Executive MBA.
After exploring opportunities in the academia and as community pharmacist I developed my career in the pharmaceutical industry were I have been working for about 12 years, initially in formulation and manufacturing within pharmaceutical development, and during the last 7 years in Clinical Supplies. I have worked for Almirall and AstraZeneca in Spain and for Galderma, Debiopharm and Incyte in Switzerland. I have recently moved back to Spain were I am still working for Incyte within the Global Clinical Supplies group.
Francisco is a Technical Sales Manager with a background in Food Engineering. He has a wide experience in advising companies in different sectors of the food industry on the use of food colours to develop and improve their products naturally. Francisco the Category Coordinator for the Dairy Category within GNT.
Dr Clemens Busse is currently working as a Senior Client Manager, Medical Devices at BSI, covering EMEA. He has worked in the IVD industry since 2009 in responsible functions for design and development and quality control.
His tasks involved research activities, project planning and budgeting, development planning, data evaluation, raw material validation, performance and stability studies, and product troubleshooting. The product range he was responsible for during his career covers manual assays to fully automated solutions.
He obtained an engineering degree in Biotechnology, followed by a PHD from the German Cancer Research Center in Heidelberg, Germany, in molecular virology.
Dr. Mahillo has 28+ years of experience in the clinical research arena, 25 of them in oncology global trials. Her areas of expertise are inmuno-oncology, including cancer vaccines, advanced therapies, genetically modified organisms and other immuno therapies. She has an in-depth knowledge on oncology networks and advocacy groups, with which she cooperates since 1999. Dr. Mahillo is a professor/magister in several Master programs administered at different Universities (Universidad Alcalá de Henares, Universidad CEU San Pablo, CESIF). She has authored of 3 books, 20 scientific articles, and 24 contributions to scientific congresses. Dr. Mahillo was awarded the first prize of the Spanish Society of Medical Oncology (SEOM) in 2015 for her project “Y Seguiré” (will keep on moving), for the promotion of clinical research. Dr. Mahillo obtained her PhD with a research on the role of multicatalytic proteinase (proteasome) as an oncology intracellular target, research line that ended up with the development of bortezomib, a proteasome inhibitor approved for the treatment of multiple myeloma patients.
